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Abstract Patients suffering obstructive sleep apnea are mainly treated with
continuous positive airway pressure (CPAP). A good compliance with this
therapy is broadly accepted as >4h of CPAP average use nightly. Although
it is a highly effective treatment, compliance with this therapy is problematic
to achieve with serious consequences for the patients’ health. Previous works
already reported factors significantly related to compliance with the therapy.
However, further research is still required to support clinicians to early antici-
pate patients’ therapy compliance. This work intends to take a further step in
this direction by building compliance classifiers with CPAP therapy at three
different moments of the patient follow-up (i.e. before the therapy starts and
at months 1 and 3 after the baseline). Results of the clinical trial confirmed
that month 3 was the time-point with the most accurate classifier reaching
an f1-score of 87% and 84% in cross-validation and test. At month 1, perfor-
mances were almost as high as in month 3 with 82% and 84% of f1-score. At
baseline, where no information of patients′ CPAP use was given yet, the best
classifier achieved 73% and 76% of f1-score in cross-validation and test set
respectively. Subsequent analyzes carried out with the best classifiers of each
time point revealed that certain baseline factors (i.e. headaches, psychological
symptoms, arterial hypertension and EuroQol visual analog scale) were closely
related to the prediction of compliance independently of the time-point. In ad-
dition, among the variables taken only during the follow-up of the patients,
Epworth and the average nighttime hours were the most important to predict
compliance with CPAP.
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1 Background
Obstructive sleep apnea (OSA) [1] is defined as repeated episodes of shallow
or paused breathing during sleep, despite the effort to breathe. This syndrome
is caused by complete or partial obstructions of the upper airway leading
to daytime sleepiness and impaired cardiopulmonary function. Gold standard
treatment of OSA involves the use of a device that administers continuous
positive pressure (CPAP) in the respiratory tract of patients [2]. Continuous
positive pressure is applied to the upper airway with a nasal mask, nasal
prongs, or a mask that covers both the nose and mouth [3] [4]. A pneumatic
splint is provided that prevents narrowing and closure of the upper airway
regardless of the site of obstruction [5]. The level of positive pressure required
to sustain patency of the upper airway during sleep should be determined in
the sleep laboratory.
Several studies aimed at objectively assess the effects of using CPAP show
that this kind of intervention is highly effective in improving symptoms, such
as daytime sleepiness, morbidity, and mortality rates related to cardiovascular
diseases [6] [7]. Although it is highly effective in minimizing OSA symptoms,
up to 36% of patients do not use or even discontinue CPAP [8] [9].
Adherence to therapy is thought to be influenced by a complex array of,
as yet, poorly characterized factors. Patient characteristics such as age, sex,
and marital status have not consistently been shown to be predictors of CPAP
adherence [10]. Severity of OSA, as determined by the apnea-hypopnea index
(AHI), oxygen desaturation index (ODI), or daytime sleepiness, have been
shown to have a weak relationship with CPAP use in some studies [11][12][13].
Furthermore, the adherence measured 3 days after CPAP initiation seems to
be a good predictor of long-term adherence [14].
Despite these efforts, the reasons that lead to compliance with therapy
remain an open field of research. Therefore a prompt detection of adherence
pattern would reduce its misuse and abandonment ratios and allow a spe-
cific approach to improving compliance. Unfortunately, there is a clear lack of
clinical analytical tools to support the early prediction of compliant patients.
When statistically analyzing possible factors that might determine CPAP
compliance, there are common complexities that compromise predictive capac-
ity and robustness of finding. The limited number of participants, the large
number of clinical variables and the quality of collected data are just to name
a few. To overcome these limitations the use of machine learning (ML) might
be an alternative solution to the aforementioned problems. Despite the numer-
ous ML applications in the medical domain, (e.g. disease diagnosis [15][16]),
compliance with therapy is usually constrained to the medication adherence
problem [17][18]. Recent ML algorithms (e.g. support vector machines [19] and
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artificial neural networks [20]) often provide highly accurate predictive models.
However, such models lack transparency and therefore their interpretation is
difficult [21]. As a consequence, other classification algorithms in the medical
field are still preferred (e.g. logistic regressions [22] or decision trees [23]).
In summary, the present study has the following objectives. On one hand,
to provide a comparative analysis of predictive methods of CPAP compliance
built using machine learning techniques in different stages of treatment. On
the other hand, to define the most important factors associated with CPAP
compliance identified by the best predictive methods obtained in the different
initial stages of therapy.
2 Methods
2.1 Participants
51 adult patients (>18years), diagnosed with OSA (15 or more apneas/hypopneas
per hour in an overnight sleep study) and requiring CPAP treatment were re-
cruited at Hospital Arnau de Vilanova (Lleida, Spain). Patients with impaired
lung function (overlap syndrome, obesity hypoventilation, and restrictive dis-
orders), severe heart failure, psychiatric disorders, periodic leg movements,
pregnancy, other dyssomnias or parasomnias, and/or a history of previous
CPAP treatment were excluded. The study was approved by the hospital ethics
committee (Approval number: CEIC-1283). All recruited patients signed an
informed consent form.
Of the 51 patients originally included in the study, 3 were excluded due to
malfunction of the CPAP machine, 5 did not attend the last visit at the sleep
unit and 1 patient died during the study.
The final sample consisted of 42 patients (29 males and 13 females) with a
mean age of 56.93+/-12.58 yrs. Their BMI was 33.83+/-6.46 and their number
of apnea or hypopneas per hour of sleep (apnea/hypopnea index or AHI) was
53.13+/-20.72 events/h. In our sample, 60% (25) of all patients were active
workers and 33% (14) were retired. The sample also had 62% of nonsmokers
(26) and 57% of nonalcohol consumers (24). In terms of CPAP device use, the
patients scored an average of nightly hours of use of 5.44+/-1.74 at month-1,
5.33+/-1.90 at month-3, 5.07+/-2.10 at month-6.
2.2 Datasets
The study variables from the 42 patients were manually collected by lung
specialists along four visits at month-0 (baseline or T0), at month-1 (T1),
at month-3 (T3) and at month-6 (T6). During the first visit clinicians gath-
ered 77 features organized in five categories: clinical history (e.g. depression,
anxiety, arterial hypertension (HTA), cardiopathy, neurological disease, res-
piratory disease), symptoms (e.g. irritability, apathy, depression, insomnia),
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co-morbidities (e.g. diabetes, obesity, dyslipidemia), therapies (e.g. beta block-
ers, diuretics), sleeping test (e.g. sleeping time, AHI, percentage of the night
spent with oxygen saturation < 90% or CT 90) and basal information (e.g.
size, weight, BMI, tas, tad, oxygen saturation). In the second visit, when the
patients had the CPAP machine at home during one consecutive month, 16
new features related to monitoring were collected (e.g. nightly average use,
abandon or adverse effects of the treatment, such as dry mouth, allergies, and
cutaneous irritations). At the third month (T3), the same number of features
as in T1 were gathered but adding 5 new ones (i.e. size, weight, BMI, drugs
removed and drugs added). At month-6, although some other variables were
collected, for the purpose of this study only the average use of nigh hours was
considered. Eventually, three datasets (D0, D1, and D3) with an incremental
number of features (i.e. D1 features = D0 features + features collected at T1)
were created with 77, 93 and 114 features. The full list of variables is described
in table s1 of the supplementary material.
In this study, we addressed CPAP compliant users as those who had more
than 4 hours on average per night during the first 6 months of treatment.
Therefore, all samples from each dataset (ds) were labeled using the collected
information about nightly hours/use on average of the CPAP device at the end
of the month-6. In so doing, 24 (57%) patients were labeled as ’compliant’, class
’1’, as they correctly followed the CPAP therapy prescription (more than 4h
nightly on average). On the contrary, 18 (43%) patients did not achieve the
prescribed treatment (minus or equal than 4 hours nightly on average) and
they were labeled as ’non-compliant’, class ’0’.
2.3 Preprocessing
Datasets D0, D1, and D3 collected at time points T0, T1 and T3, respectively,
were statistically described for a better understanding of the sample. In this
task, the Mann-Whitney U test was used to evaluate the statistical significance
of quantitative variables with CPAP compliance and Chi-square tests for qual-
itative characteristics. Previously, the categorical features were converted into
numerics to achieve a homogeneous data type sample. Variables with only two
categories were directly mapped into binary values. Variables with more than
two categories, given their underlying incremental meaning, were mapped into
unsigned ordinal values.
Afterwards, we carried out a set of preprocessing tasks to reduce possible
noise and redundancy in the datasets. First, given the existence of null values
in the datasets, an imputation process was carried out consisting of computing
the mode for the categorical characteristics and the mean for the numerical
characteristics. Subsequently, the distributions of the categorical characteris-
tics were analyzed, which revealed variables with few individuals by category.
The features with a number of individuals below a threshold were removed
from the study to avoid the noise they might introduce when building pre-
dictive models. To catch up possible information redundancy in the datasets,
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we computed the mutual information [24] score for the categorical variables
in a pair-wise manner. From each pair, we kept the variable more statistically
significant with the dependent variable using Chi-square test. Among the nu-
merical features, we applied a correlation analysis to detect highly redundant
features. Given the existence of non-normally distributed numerical features,
we used the Spearman correlation method on all numerical variables in a pair-
wise manner. Empirically we set-up a threshold for the correlation scores above
of which one feature of the pair was removed (i.e. the feature with the highest
p-value). P-values less than 0.05 were considered statistically significant.
2.4 Classification Framework
All preprocessed datasets presented common particularities such as a small
number of samples, the presence of missing values, class unbalance and high
multidimensionality feature space. To cope with these complexities we de-
signed a classification framework flexible enough to enable the execution of
heterogeneous pipelines or sequence of configurable machine learning steps. In
particular, the pipelines were composed of three mandatory steps (i.e. impu-
tation, variance filtering and data standardization), two optional steps (i.e.
feature selection and feature sampling) and two more final steps (i.e. clas-
sifier training and evaluation). In total 80 pipelines were configured from 4
feature selection methods, 5 classifier algorithms, 2 sampling strategies and 2
evaluation metrics.
The result of running (i.e. training or building) a pipeline (Pipei) on a
dataset (Dj) with parameters (paramsi) is a predictive model or classifier
(Mi,j) with its associated predictive performance (Perfi,j). Figure 1 shows the
scheme with the inputs, outputs and the different steps that configure the
pipelines for compliance with CPAP therapy.
The first step of a pipeline is the imputation of null values. To do this, given
the small proportion of null values in the datasets, a simple strategy was pro-
posed to replace the null values with their most frequent value (for categorical
characteristics) and with the mean value (for numerical characteristics).
The second step consists of a simple filter method to eliminate features with
zero variance, that is, to eliminate these characteristics that have the same
value in all the samples and that do not provide any additional information
to the data set.
Since the data come from different sources, the next step is to standard-
ize the data. This step consisted of homogenizing all features to zero mean
and variance one. This transformation step is crucial for the construction of
many classification algorithms since it allows them to compare features with-
out harming their performance or execution time [25].
Feature selection (fs) was introduced in the pipelines given a large number
of features compared with the number of samples for each dataset (p > n).
This type of methods aims to reduce over-fitting by improving model perfor-
mance and generalization, to provide faster and more cost-effective models and
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simplify models making them easier to interpret [26]. Feature selection meth-
ods are usually divided into three categories: filter, wrapper, and embedded
[27]. Filter methods, in general, examine features individually with the class,
wrapper methods use a predictive model to generate subsets of features evalu-
ated according to their predictive power, and embedded methods search for an
optimal subset of features during the training of the prediction model. In this
study, we used one method for each of the different feature selection strategies.
For the filter-based strategy, we defined a simple method (combine_fs) that
makes a ranking of the features by their statistical significance with the class
(i.e. applying ANOVA or chi-squared tests according to the data type of the
characteristics). Then, this method returns the subset of features through a
configurable threshold. For the wrapper strategy, we proposed the recursive
feature elimination (rfe_rf_fs) method [28] configured with a random forest
to provide the importance of the features. The embedded strategy was entitled
to the application of a linear model configured with the L1 norm (lasso_fs)
[29]. It was also considered the possibility of not using any method of feature
selection.
The next step is data sampling (sm). In particular, we proposed the use of
the smote sampling method [30]. This method consists of creating synthetic
samples (i.e. detecting similar instances and performing small perturbations in
their values) of the under-represented class samples instead of creating copies,
as the over-sampling method would do. The main idea behind this method
is to avoid the bias produced by many standard classifier learning algorithms
towards the class with a larger number of instances.
Regarding the training and evaluation stage, we selected several classifica-
tion algorithms (cls) to deal with various classification strategies (i.e. linear,
non-linear, distance-based and tree-based). In fact, the provision of different
classification strategies is especially appropriate in complex datasets when the
distribution of data is not clearly manifested. As early mentioned in the paper,
the interpretability of the resulting predictive models is also a desired condi-
tion. Therefore, we opted for logistic regression (LR) [22], k-nearest neighbor
(k − NN) [31] and random forest (RF ) [32] for the subset of interpretable
classification algorithms (termed descriptive within the study). In contrast,
we chose support vector machines (SVM) [19] and artificial neural networks
(NN) [20] for the subset of algorithms with less interpretative capacity but
with a potential greater discriminatory capacity (i.e. referred to as non de-
scriptive).
2.5 Evaluation Setup
In order to ensure adequate performance evaluation, the available data were
stratified and randomly divided into train (29 rows, 12 non-compliant and 17
compliant) and test (13 rows, 6 non-compliant and 7 compliant) sets with a
ratio of 70/30. Therefore, the training set partitions of the three data sets (D0,
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D1, and D3) contained the same individuals. The same rule applies for the test
set.
Test sets remained untouched until the end of the process. Training sets
were used for 10-fold cross-validation to enable proper model tuning and eval-
uation. This technique is particularly suitable when the sample size is small.
Indeed, as suggested in [33] the entire sequence of processes that composed
each pipeline was wrapped-up within the cross-validation technique in order to
reduce the possibility of obtaining too optimistic or pessimistic results. Thus,
training data were randomly split into stratified train-validation sets (20 rows,
8 non-compliant and 12 compliant) and stratified test-validation sets (9 rows,
4 non-compliant and 5 compliant) following a ratio of 70/30. Then, for each
of the configured pipelines (i.e. 80 pipelines), we created as many experiments
as combinations of values for the different hyper-parameters defined for each
method of the pipeline (table 1).
Table 1 Different pipeline parameters tested using grid-search and 10-fold CV.
Pipeline Step Parameter Options
Combine_fs percentile = [5, 10, 20, 30, 40, 50]
Lasso_fs
estimator = Logistic Regression
penalty = "l1"
C = [5, 10, 20, 30, 40, 50]
RFE_RF_fs
class_weight = ’balanced’
n_estimators = 100
step = [0,1 ]
n_features_to_select = [0.4,0.6,0.8]
Smote_fs
n_neighbors = [3,4,5]
ratio=’auto’
kind=’regular’
K-NN n_neighbors = [1,3,5,7,9,11]weights = [’uniform’, ’distance’]
LR
C = [0.00001,0.0001,0.0005,0.001,0.005,0.01,0.05,0.1,0.5,1,5,10,15,30]
class_weight = [None, ’balanced’]
penalty = [’l1’, ’l2’]
RF
n_estimators = [100,150,200,250,500]
criterion = [’entropy’,’gini’]
max_depth = [’None’,4,6]
class_weight = [None, ’balanced’]
SVM
C = [0.01,0.1,0.5,1,5,10,15,30,50]
gamma = [0.0001,0.001,0.01, 0.1,1,5]
kernel = ’radial’
class_weight = [None, ’balanced’]
NN
alpha = [1e− 5,0.00001,0.0001,0.001,0.01,0.1,1,3,5,10]
hidden_layer_sizes = [(30,),(50,),(70,),(100,),(150,),
(30,30),(50,50),(70,70),(100,100),
(30,30,30),(50,50,50),(70,70,70)]
8 Xavier Rafael-Palou et al.
We performed 10-fold cross-validation for all experiments in each pipeline.
This process was repeated twice, one for each of the proposed learning met-
rics (i.e. f1-weighted and precision-weighted). The learning metric, f1-weighted
(f1), was selected since it is a suitable measure for unbalanced datasets. This
metric combines the precision and recall metrics weighted by the number of
samples per each class. The other selected metric, precision-weighted (prec),
tends to prefer classifiers with less incorrect compliant predicted patients,
which indeed they are the most harmful cases to avoid. This metric com-
putes the ratio of correctly classified cases (i.e. compliant patients) among all
positive classified cases weighted by the number of samples per each class.
As a result of this 10-fold cross-validation process, we reported for each
experiment the average and standard deviation performance of the learning
metric with which the pipeline was configured. A greedy-search strategy was
applied to select the best experiment, i.e. best pipeline parameterization. Addi-
tionally, with the intention to avoid the possible bias introduced in this process
[34], we evaluated each best pipeline parameterization (i.e. pipelines with the
appropriated values for their hyper-parameters) using a final outer stratified
10-fold cross-validation on the training data (i.e. with learning metric=f1-
weighted, ratio=70/30 for cv-train and cv-test). As a result of this process
we reported the final cross-validation performance (f1-score) of the pipelines.
This score was provided by the f1-weighted metric since although having a high
precision is desirable, a high recall (rec) is also needed especially for health
institutions since it reduces false negatives and thus non-necessary clinical
interventions and additional costs.
This whole process was repeated 80 times for all pipelines of each dataset.
The best pipelines of each dataset were identified by ranking the cross-validation
performances (i.e. f1-score) reported by each pipeline. The best pipelines of
each dataset were compared together in order to find statistically significant
differences. We did the same among the best descriptive and non-descriptive
pipelines. To do this, we used a 10-fold cross-validated paired t-test.
To complete the reporting of this analysis, we computed on the test set
and for each of the best pipelines of each dataset a comprehensive set of
scores (i.e. f1, precision, recall, AUC and confusion matrix) to enable a better
understanding of the results. Also, we reported their ROC and learning curves.
2.6 Feature Importances
We reported the most important features from the best descriptive pipelines
(in this study we only used those configured with random forest and logistic
regression) for each dataset. To do this, we performed a ranking of features
using a stability score [35]. This score measures how "stable" are the features
of a predictive model. For this, we build n times a pipeline using n random
subsets of fixed size s.
To compute this score, we created (n = 100) randomly stratified partitions
from the (s = 70%) of the entire dataset. For each data partition, we trained
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the best pipelines and keep a record of the selected features of the classifier and
their weights (or feature importances for RF classifier). With this information,
we computed the number of times any feature was selected (i.e. stability score)
and its normalized absolute average weight (or importance). Since one classifier
might report all features as relevant (i.e. non-zero), a threshold (t > 0.4) in
the weights was empirically defined to make usable the stability score.
3 Results
3.1 Data preprocessing
A descriptive analysis of the initial data sets was carried out and summarized
in tables (s2,s4,s6) of the supplementary material. In total (11/27/42) features
had null values with ratios between 2.3% and 12% from the total number of
rows. After the null imputation, we found (14/7/10) variables with underrep-
resented categories (<= 10% of rows per category ). We also detected 4 pairs
of categorical features (i.e. no active, anti-depressives, ADO and memory dis-
orders) in the D0 with MI scores above 50%. From the correlation analysis
applied on the numerical variables, we found 4 highly (> 80%) redundant fea-
tures in D0 (i.e. abdomen and hip circumference, weight and CT90%) and 4
features in D3 (i.e. size_3, weight_3, bmi_3 and total_use_hours_3). After
the removal of these features, the final datasets were composed of (54/63/70)
variables.
3.2 Classification analysis
Eventually, we evaluated 76 out of 80 initially configured pipelines for each
dataset. In particular, we rule out pipelines which had same classification
algorithm (i.e. random forest) for feature selection and classification given
their initial poor contribution to the experimental results and the long runtime
required to complete their evaluation.
Best pipelines (p0, p1, p3) for D0, D1 and D3 achieved 0.73+/-0.18, 0.82+/-
0.06, 0.87+/- 0.15 of f1-score in cross-validation and 0.76, 0.84, 0.84 in test
set (Table 2). These pipelines were configured with precision-weighted met-
ric and SVM algorithm for the D0 dataset; with smote sampling, f1-weighted
metric and an SVM for the D1 dataset and with lasso feature selection, smote
sampling, precision-weighted metric and an RF for the D3 dataset.
To visually support these values, figures (3, 4, and 5) show the area under
the receiver operating characteristic (ROC) curves and figures (6, 7, and 8)
show the learning curves with the effects of increasing the size of the training
set in their performances.
We also analyzed what was the contribution in classification performance
of the different techniques configured in the pipelines (i.e. sampling strategy,
feature selection, learning metric and classification algorithm). In particular,
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Table 2 Performances of the best pipelines in each dataset.
id ds sm fs metric cls params
p0 D0 none none precision_weighted SVM [0.001, balanced, 30]
p1 D1 Smote none f1_weighted SVM [0.001, None, 4, 15]
p3 D3 Smote Lasso_fs precision_weighted RF [1, 250, gini, 4, None, None]
id cv_prec cv_rec cv_f1 test_prec test_rec test_f1
p0 0.78+/-0.2 0.74+/-0.17 0.73+/-0.18 0.77 0.85 0.76
p1 0.84+/-0.06 0.82+/-0.05 0.82+/-0.06 0.85 0.88 0.84
p3 0.89+/-0.14 0.88+/-0.14 0.87+/-0.15 0.85 0.88 0.84
Table 3 Performance comparison between best pipelines for each dataset.
Pipelines Difference (cv_f1) statistic p_value
p0 vs p1 0.09 +/- 0.15 -1.71 0.1201
p0 vs p3 0.14 +/- 0.18 -2.70 0.0241
p1 vs p3 0.05 +/- 0.14 -1.0931 0.3027
the average in the performance (i.e. f1-score) of all pipelines using the sampling
strategy was (0.59+/-0.07,0.61+/-0.09,0.75+/-0.09) for each dataset. In con-
trast, not using any sampling strategy was (0.58+/-0.07,0.62+/-0.08,0.75+/-
0.08). Concerning the average performance reached among the pipelines config-
ured with the best feature selection methods they scored (0.59+/-0.03,0.63+/-
0.07,0.77+/-0.08). In contrast, the average in performance reached by the
pipelines without using any feature selection was (0.66+/-0.07,0.68+/-0.11,0.77+/-
0.09) respectively. Focusing in the evaluation metric with which the pipelines
were configured, the pipelines with f1-weighted metric achieved an average in
the performance of (0.58+/-0.07,0.62+/-0.09,0.76+/-0.09) while the pipelines
configured with precision-weighted obtained an average performance of (0.59+/-
0.07,0.61+/-0.09,0.75+/-0.09). Regarding the type of classification algorithm
(figure 2), the best pipelines reported performances in cross-validation be-
tween 0.59+/-0.21 (using k-NN) and 0.73+/-0.18 (using SVM) of f1-score in
D0. In D1 the best pipelines reported performances between 0.61+/-0.12 (us-
ing K-NN) and 0.82+/-0.06 (with SVM). In D3 the best pipelines reported
performances between 0.75+/-0.07 (using k-NN) and 0.87+/-0.15 (with RF).
Table 4 summarizes these differences of performance among the configured
pipelines.
Regarding the comparison of performance between descriptive and non-
descriptive pipelines, the best descriptive pipelines obtained f1-scores of 0.69
+/-0.15, 0.75 +/- 0.15 and 0.87 +/- 0.15 in cross-validation and 0.76, 0.84,
0.84 in test set, while the best non-descriptive pipelines obtained scores of 0.73
+/-0.18, 0.82 +/- 0.06 and 0.84 +/- 0.08 in cross-validation and 0.76, 0.84,
0.84 in test set. Further details about these pipelines can be found in table 5.
To complete the analysis we extracted the most important features used
by the best descriptive pipelines. In total (25/28/20) features were reported
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Table 4 Performance difference of f1 cross-validation along the different datasets achieved
among pipelines configured with different techniques.
D0 D1 D3
Methods Comparisons Avg Max Avg Max Avg Max
Sampling Smote vs None 0.01 -0.02 -0.01 0.04 0.0 0.02
Feature Selection Best vs None -0.07 -0.07 -0.05 -0.13 0.0 0.02
Metrics f1 vs prec 0.01 0.02 0.01 0.04 0.01 -0.01
Classifier Algorithm Best vs Worst 0.09 0.14 0.14 0.21 0.19 0.20
Table 5 Best descriptive and non-descriptive pipelines by dataset.
ds sm fs metric cls params
D0 none none prec SVM [0.001, balanced, 30]
D0 Smote none prec LR [None, 15, 4, l2]
D1 Smote none f1 SVM [0.001, None, 4, 15]
D1 none none f1 LR [None, 5, l2]
D3 Smote lasso_fs prec RF [1, 250, gini, 4, None, None]
D3 none none f1 LR [None, 0.5, l1]
for each dataset after setting up a minimum threshold of 0.4 in the feature
weights. Top-10 features of D0 and D1 reported stability scores above 0.6. In
D3 only 2 features were above 0.4 of stability score. Figures (9, 10, and 11)
provides a visual ranking of the features of each of the dataset ordered by the
stability score.
4 Discussion
This study is the first attempt to predict compliance with the CPAP therapy in
patients with OSA at different points of the treatment by building classifiers.
A good CPAP compliance has been demonstrated to reduce cardiovascular
risk and symptoms in patients with sleep apnea. The identification of a spe-
cific group of patients with a predicted poor compliance could allow focusing
resources and capitals on this specific group for improving its compliance.
Results have shown that the D0 dataset, collected before the start of treat-
ment, is the most complex to learn compared to D1 and D3, collected at
months 1 and 3 of the patient’s therapy. Nevertheless, a considerable average
f1-score of 0.73 +/- 0.18 was achieved in cross-validation and 0.76 in the test
set. As shown in table 3, an important performance increase of 0.09 (p = 0.12)
was reached in D1 with respect to D0. In D3, we get the best classification
performance with a significant increase of 0.14 in f1-score (p = 0.024) with re-
spect to D0. This same trend occurred in the test set where the best pipelines
of D1 and D3 reported performances of 0.18 above the achieved in D0. The
difference in f1-score between D3 and D1 did not prove to be significant (p
= 0.30). These results seem to confirm that follow-up measurements help to
increase baseline prediction performance. Indeed the closer to the CPAP com-
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pliance cut-off we are the more confident is the classifier (i.e. performance in
D0 is minor than performance in D1 and minor than D3). In addition to that,
patterns of CPAP adherence appear early, in our case at 1 month, since it
is when the greatest performance increase is achieved. This same finding was
confirmed by other studies [14] [36].
During the evaluation step, we realized the use of sampling, feature se-
lection or a particular learning metric were not as substantial as expected in
any of the datasets (table 4). To be more specific, the maximum performance
increase, regardless of the method used, was between 0.02 and 0.04 of f1-score
in cross-validation. Probably this confined contribution was due to the initial
preprocessing and the fact that the data were not severely unbalanced. Indeed,
in D0 and D1 the use of feature selection compromised the performances with
a maximum decrease of 0.13. In contrast, important increments of performance
in all datasets were produced depending on the classification algorithm used
(i.e. 0.14, 0.21 and 0.20). In D0 and D1 best pipelines were using an SVM.
This result was not surprising because this algorithm has been already re-
ported suitable for problems with few samples and with a high number of
features [37] being able to build complex non-linear decision boundaries. In
D3 the best pipeline was configured with an RF although the one with SVM
also provided a high score. RF algorithm is also suitable for difficult problems
and especially indicated for handling categorical features [32]. The other non-
descriptive classifier (i.e. NN) reported competent performances in all three
datasets, especially in D3, where it exceeded the results reported by the best
pipeline configured with an SVM. However, the K-NN algorithm reported the
worst scores on the three data sets. This is partly because it does not usually
work well with a large number of features [38].
Focusing on the differences of performance between the best descriptive
and non-descriptive pipelines, those were always below 0.1 and not signifi-
cant (p=0.14) for D0 but significant in D1 (p=0.02). In contrast, the best
performance in D3 was achieved through a descriptive classifier although in
cross-validation the difference in performance with the best non-descriptive
pipeline (0.02+/-0.16 of f1-score) proved to be non-significant (p=0.69).
Regarding the relevant factors related to the CPAP compliance prediction,
four baseline features were found common in each of the best pipelines for
the different datasets collected at time-points (T0, T1, and T3). Those were
headaches, psychological symptoms (i.e. irritability, apathy, and depression),
arterial hypertension and the visual analog scale (as part of EuroQol question-
naire). From these four features, the headache was the most stable feature (i.e.
with the highest stability score) at T0 and T1. In the baseline, all these char-
acteristics were found significant with respect to the CPAP compliance but
the latter (p=0.079). In particular, compliant patients were more likely to not
having headache (85%, 23 out of 27) nor psychological symptoms (67%, 18 out
of 27), having arterial hypertension (74%, 20 out of 27) and worst visual ana-
log scale score (9.15+/-1.02 on mean difference with respect to non-compliant
patients). To our knowledge, these features together have not previously been
reported as relevant to predict patient compliance with CPAP therapy at ei-
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ther month 0, 1 and 3. In the literature, having morning headache was also
found significant in a randomized control trial of OSA patients [39]. In con-
trast, psychological factors did not show prediction capability in [40][41][42]
but how patients were challenging difficult situations (active versus passive)
[43]. In [44], authors evidenced the positive effect of CPAP treatment on blood
pressure in patients with resistant hypertension. The visual analog scale, used
as a generic method for measuring the quality of life, was reported useful to
track treatment-induced changes in [45][46].
Different studies [47][48] [49] have shown an improvement in snoring, gas-
troesophageal reflux and oxygen saturation with CPAP treatment. In our sam-
ple, only oxygen saturation (p < 0.001) predicted good compliance with CPAP.
However, these were found among the characteristics with the highest stability
scores for the best pipelines of month-0 and month-1.
Two of the features collected at months 1 and 3 (i.e. average hours of nightly
CPAP use and Epworth) were found among the most important predictive
features in these time-points. These features were significant regarding CPAP
compliance. Interestingly, from months 1 to 3 the average of nightly hours of
use for compliant users increased (from 5.9+/-1.51 to 6.17+/-1.29) while in
non-compliant users decreased (from 4.4+/-1.75 to 3.56+/-1.76). In contrast,
the average of Epworth for compliant users decreased from 5.48+/-3.63 to
4.64+/-3.07, while for non-compliant increased from 7.33+/-3.7 to 8.46+/-
4.16). Early measurements of the average hours of nightly CPAP use were
already reported as predictive of CPAP compliance in [50][51]. Epworth was
also reported as a relevant predictor of compliance in [14][52][53][51].
The limitations of this study come from two sides. First, although a com-
mon cut-off was selected for the definition of CPAP compliance, changes in this
threshold might cause different performances as well as variations in the rank
of the feature importance reported in this work, thus further explorations are
required in this regard. Second, even the positive scores obtained by the pre-
dictive models at the different time-points, the reduced number of individuals
in the sample produces appreciable variations in their performance. Therefore
collecting more data could help to validate the presented findings.
5 Conclusions
To the best of our knowledge, this article is the first attempt to analyze and
compare the compliance with the CPAP therapy of patients with OSA at dif-
ferent points of the treatment by building classifiers. Three time-points were
established to perform the analysis (i.e. before the treatment starts, after one
month and at the month 3). To build and evaluate the classifiers a flexible
framework was designed relying on machine learning pipelines. High perfor-
mances were reached yet after one month of treatment, being the third month
when significant differences in performances were achieved with respect to the
baseline. Four baseline variables were reported relevant for the prediction of
compliance with CPAP at each time-point. Two characteristics more, collected
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during the follow-up, were also highlighted for the prediction of compliance at
months 1 and 3. Further tasks are devised to extend the present study, in-
cluding the collection of new patients and exploring other CPAP compliance
cut-offs, in order to validate the findings and reported performances. This
work has intended to take a step forward towards the creation of new tools to
allow early and accurate detection of patients struggling to follow the CPAP
treatment and thus enable personalized patient interventions that would lead
to improving their quality of life.
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Figures
Fig. 1 Pipeline steps designed for building classifiers for compliance with the CPAP therapy.
Fig. 2 Performance results reached in cross-validation and test by the best pipelines at the
different time-points..
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Fig. 3 ROC curves for cross-validation and test of the best pipeline for dataset D0.
Fig. 4 ROC curves for cross-validation and test of the best pipeline for dataset D1.
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Fig. 5 ROC curves for cross-validation and test of the best pipeline for dataset D3.
Fig. 6 Learning curves of the best pipeline for dataset D0.
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Fig. 7 Learning curves of the best pipeline for dataset D1.
Fig. 8 Learning curves of the best pipeline for dataset D3.
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Fig. 9 Stability scores and feature weights of the best pipeline for dataset D0.
Fig. 10 Stability scores and feature weights of the best pipeline for dataset D1.
Fig. 11 Stability scores and feature weights of the best pipeline for dataset D3.
